| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| ALIGNMENT HEALTHCARE Aktie jetzt für 0€ handeln | |||||
| Mi | Medicare Advantage Company Alignment Healthcare Shows Huge, Unusual Call Option Activity | 1 | Barchart.com | ||
| 14.05. | Alignment Healthcare USA, LLC: Alignment Health Plan Recognized as One of Four Medicare Advantage Prescription Drug Plans in the U.S. for 2026 Excellence in Quality | 1 | GlobeNewswire (USA) | ||
| 13.05. | Alignment Healthcare (ALHC) Climbs 7% Ahead of Business Updates | 1 | Insider Monkey | ||
| 13.05. | Alignment Healthcare CEO Adds Chairman Role As Medicare Business Grows | 1 | Forbes | ||
| 12.05. | Alignment Healthcare CEO John Kao adds chairman role | 3 | Investing.com | ||
| 12.05. | Alignment Healthcare Strengthens Leadership Team to Support Long-Term Growth and Shareholder Value Creation | 425 | GlobeNewswire (Europe) | ORANGE, Calif., May 12, 2026 (GLOBE NEWSWIRE) -- Alignment Healthcare, Inc. (NASDAQ: ALHC) today announced leadership updates that further strengthen the organization as the company continues to scale... ► Artikel lesen | |
| 12.05. | Alignment Healthcare, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| 12.05. | Alignment Healthcare gains on SmallCap 600 addition; Sun Country Airlines removed | 2 | Seeking Alpha | ||
| 12.05. | S&P Dow Jones Indices: Alignment Healthcare Set to Join S&P SmallCap 600 | 201 | PR Newswire | NEW YORK, May 11, 2026 /PRNewswire/ -- Alignment Healthcare Inc. (NASD: ALHC) will replace Sun Country Airlines Holdings Inc. (NASD: SNCY) in the S&P SmallCap 600... ► Artikel lesen | |
| 05.05. | Can Alignment Healthcare (ALHC) Climb 32.61% to Reach the Level Wall Street Analysts Expect? | 1 | Zacks | ||
| 01.05. | Alignment Healthcare forecasts $138M-$163M adjusted EBITDA for 2026 as membership outlook rises to 294,000-299,000 | 1 | Seeking Alpha | ||
| 30.04. | Alignment Healthcare Turns A Profit As Medicare Advantage Costs Ease | 3 | Forbes | ||
| 17.04. | Wolfe Research stuft Alignment Healthcare mit "Outperform" ein | 4 | Investing.com Deutsch | ||
| 17.04. | Wolfe Research initiates Alignment Healthcare stock at outperform | 1 | Investing.com | ||
| 16.04. | Top 10 Healthcare stocks by forward P/E: From Capricor's 418x to Alignment Healthcare's 48x | 10 | Seeking Alpha | ||
| 08.04. | Alignment Healthcare (ALHC) Soars 16% on Medicare Reimbursement Hike | 16 | Insider Monkey | ||
| 07.04. | Crude Oil Gains 3%; Alignment Healthcare Shares Jump | 2 | Benzinga.com | ||
| 07.04. | UnitedHealth, Alignment Healthcare, Humana And Other Big Stocks Moving Higher On Tuesday | 9 | Benzinga.com | ||
| 03.03. | Sekundärplatzierung belastet Alignment Healthcare-Aktie | 2 | Investing.com Deutsch | ||
| 03.03. | Alignment Healthcare prices 13.2M share secondary offering at $19.46 | 1 | Seeking Alpha |
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| BRIGHTSPRING HEALTH SERVICES | 59,08 | +0,84 % | BrightSpring Health Services, Inc. Reports First Quarter 2026 Financial Results and Increases Full Year 2026 Guidance | LOUISVILLE, Ky., May 01, 2026 (GLOBE NEWSWIRE) -- BrightSpring Health Services, Inc. ("BrightSpring" or the "Company") (NASDAQ: BTSG), a leading provider of home and community-based health services... ► Artikel lesen | |
| FRESENIUS | 40,150 | -0,05 % | EQS-PVR: Fresenius SE & Co. KGaA: Veröffentlichung gemäß § 40 Abs. 1 WpHG mit dem Ziel der europaweiten Verbreitung | EQS Stimmrechtsmitteilung: Fresenius SE & Co. KGaA
Fresenius SE & Co. KGaA: Veröffentlichung gemäß § 40 Abs. 1 WpHG mit dem Ziel der europaweiten Verbreitung
15.05.2026 /... ► Artikel lesen | |
| BILLIONTOONE | 83,01 | -0,44 % | Jim Cramer on BillionToOne: "I Say Buy It" | ||
| PROGYNY | 25,280 | -1,40 % | Canaccord upgrades Progyny stock rating to buy on guidance beat streak | ||
| GENEDX | 46,760 | +4,54 % | GeneDx (WGS) Fell Despite Continued Execution Improvement | ||
| SIEMENS HEALTHINEERS | 34,590 | +1,05 % | ANALYSE-FLASH: Jefferies senkt Ziel für Siemens Healthineers auf 50 Euro - 'Buy' | NEW YORK (dpa-AFX) - Das Analysehaus Jefferies hat das Kursziel für Siemens Healthineers von 60 auf 50 Euro gesenkt, aber die Einstufung auf "Buy" belassen. Mit der Sparte Bildgebende Verfahren und... ► Artikel lesen | |
| PROCEPT BIOROBOTICS | 28,910 | +2,85 % | PROCEPT BioRobotics Reports First Quarter 2026 Financial Results | SAN JOSE, Calif., April 29, 2026 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics® Corporation (Nasdaq: PRCT) (the "Company"), a surgical robotics company focused on advancing patient care by developing transformative... ► Artikel lesen | |
| FRESENIUS MEDICAL CARE | 38,990 | +1,25 % | Shortseller-Positionen aktuell: u.a. Evotec, FMC, Gerresheimer, Hypoport, Nagarro, Nordex, Suss MicroTec | Wer Aktien leerverkauft, also auf fallende Kurse spekuliert (Shortselling), unterliegt bestimmten Transparenzpflichten. Aktuelle Meldungen über Leerverkäufe geben Aufschluss darüber. Diese Vorgaben... ► Artikel lesen | |
| HEARTFLOW | 27,520 | +0,58 % | Heartflow, Inc.: Heartflow Reports First Quarter 2026 Financial Results and Raises Full Year 2026 Guidance | SAN FRANCISCO, May 14, 2026 (GLOBE NEWSWIRE) -- Heartflow, Inc. (Heartflow) (Nasdaq: HTFL), the leader in AI technology for coronary artery disease (CAD), today reported financial results for the... ► Artikel lesen | |
| ONCOLOGY INSTITUTE | 4,160 | -0,95 % | The Oncology Institute GAAP EPS of -$0.02 beats by $0.07, revenue of $147.4M beats by $5.42M | ||
| GMR SOLUTIONS | 11,260 | -3,60 % | Nach Börsengang: GMR Solutions löst Vorzugsaktien ab und passt Corporate Governance an | ||
| AVEANNA HEALTHCARE | 7,620 | -0,78 % | Aveanna Healthcare Holdings, Inc: Aveanna Healthcare Holdings Announces First Quarter Financial Results and Revised 2026 Guidance | First Quarter Revenue was $647.9 million, a 15.9% increase over the prior year periodFirst Quarter Net income was $41.7 million compared to $5.2 million for the prior year periodAdjusted EBITDA for... ► Artikel lesen | |
| ALPHA TAU MEDICAL | 11,050 | -1,16 % | Alpha Tau Medical Ltd.: Alpha Tau Announces First Quarter 2026 Financial Results and Provides Corporate Update | - Groundbreaking interim results from U.S. REGAIN trial in recurrent glioblastoma demonstrate 100% local disease control, 67% complete response rate, and favorable safety profile - - Completion of... ► Artikel lesen | |
| ANTERIS TECHNOLOGIES GLOBAL | 8,780 | +1,86 % | ANTERIS TECHNOLOGIES GLOBAL CORP.: Initial Director's Interest Notice x 2 | ||
| CO-DIAGNOSTICS | 3,880 | +62,34 % | Co-Diagnostics Reports First Quarter 2026 Financial Results | Advancing Global Commercialization Through CoSara Regulatory Progress and Regional Expansion
Executing Clinical Strategy with Upper Respiratory Submission Preparation... ► Artikel lesen |